180 related articles for article (PubMed ID: 36888630)
1. Induction of fetal hemoglobin: Lentiviral shRNA knockdown of HBS1L in β0-thalassemia/HbE erythroid cells.
Chumchuen S; Sripichai O; Jearawiriyapaisarn N; Fucharoen S; Peerapittayamongkol C
PLoS One; 2023; 18(3):e0281059. PubMed ID: 36888630
[TBL] [Abstract][Full Text] [Related]
2. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
[TBL] [Abstract][Full Text] [Related]
3. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
[TBL] [Abstract][Full Text] [Related]
4. Genetic modifiers of β-thalassemia and clinical severity as assessed by age at first transfusion.
Danjou F; Anni F; Perseu L; Satta S; Dessì C; Lai ME; Fortina P; Devoto M; Galanello R
Haematologica; 2012 Jul; 97(7):989-93. PubMed ID: 22271886
[TBL] [Abstract][Full Text] [Related]
5. Disruption of the Hbs1l-Myb locus causes hereditary persistence of fetal hemoglobin in a mouse model.
Suzuki M; Yamazaki H; Mukai HY; Motohashi H; Shi L; Tanabe O; Engel JD; Yamamoto M
Mol Cell Biol; 2013 Apr; 33(8):1687-95. PubMed ID: 23428869
[TBL] [Abstract][Full Text] [Related]
6. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
[TBL] [Abstract][Full Text] [Related]
7. Influences of genetic variation on fetal hemoglobin.
He Y; Lin W; Luo J
Pediatr Hematol Oncol; 2011 Nov; 28(8):708-17. PubMed ID: 22023465
[TBL] [Abstract][Full Text] [Related]
8. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
[TBL] [Abstract][Full Text] [Related]
9. A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E.
Nuinoon M; Makarasara W; Mushiroda T; Setianingsih I; Wahidiyat PA; Sripichai O; Kumasaka N; Takahashi A; Svasti S; Munkongdee T; Mahasirimongkol S; Peerapittayamongkol C; Viprakasit V; Kamatani N; Winichagoon P; Kubo M; Nakamura Y; Fucharoen S
Hum Genet; 2010 Mar; 127(3):303-14. PubMed ID: 20183929
[TBL] [Abstract][Full Text] [Related]
10. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
11. IOX1 Fails to Reduce α-Globin and Mediates γ-Globin Silencing in Adult β
Khamphikham P; Wongborisuth C; Pornprasert S; Tantiworawit A; Tangprasittipap A; Songdej D; Hongeng S
Exp Hematol; 2022; 112-113():9-14.e7. PubMed ID: 35839944
[TBL] [Abstract][Full Text] [Related]
12. Existence of HbF Enhancer Haplotypes at
Cyrus C; Vatte C; Borgio JF; Al-Rubaish A; Chathoth S; Nasserullah ZA; Jarrash SA; Sulaiman A; Qutub H; Alsaleem H; Alzahrani AJ; Steinberg MH; Ali AK
Biomed Res Int; 2017; 2017():1972429. PubMed ID: 28280727
[No Abstract] [Full Text] [Related]
13. Variability of hemoglobin F expression in hemoglobin EE disease: hematological and molecular analysis.
Pakdee N; Yamsri S; Fucharoen G; Sanchaisuriya K; Pissard S; Fucharoen S
Blood Cells Mol Dis; 2014; 53(1-2):11-5. PubMed ID: 24581976
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
[TBL] [Abstract][Full Text] [Related]
15. Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia.
Nualkaew T; Sii-Felice K; Giorgi M; McColl B; Gouzil J; Glaser A; Voon HPJ; Tee HY; Grigoriadis G; Svasti S; Fucharoen S; Hongeng S; Leboulch P; Payen E; Vadolas J
Mol Ther; 2021 Sep; 29(9):2841-2853. PubMed ID: 33940155
[TBL] [Abstract][Full Text] [Related]
16. A functional element necessary for fetal hemoglobin silencing.
Sankaran VG; Xu J; Byron R; Greisman HA; Fisher C; Weatherall DJ; Sabath DE; Groudine M; Orkin SH; Premawardhena A; Bender MA
N Engl J Med; 2011 Sep; 365(9):807-14. PubMed ID: 21879898
[TBL] [Abstract][Full Text] [Related]
17. A combined approach for β-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction.
Zuccato C; Breda L; Salvatori F; Breveglieri G; Gardenghi S; Bianchi N; Brognara E; Lampronti I; Borgatti M; Rivella S; Gambari R
Ann Hematol; 2012 Aug; 91(8):1201-13. PubMed ID: 22460946
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of Sardinian beta0 thalassemia by genetic modifiers.
Galanello R; Sanna S; Perseu L; Sollaino MC; Satta S; Lai ME; Barella S; Uda M; Usala G; Abecasis GR; Cao A
Blood; 2009 Oct; 114(18):3935-7. PubMed ID: 19696200
[TBL] [Abstract][Full Text] [Related]
19. BCL11A-targeted γ-globin gene induction by triterpenoid glycosides of Fagonia indica: A preclinical scientific validation of indigenous herb for the treatment of β-hemoglobinopathies.
Iftikhar F; Khan MBN; Tehreem S; Kanwal N; Musharraf SG
Bioorg Chem; 2023 Nov; 140():106768. PubMed ID: 37586133
[TBL] [Abstract][Full Text] [Related]
20. POGZ Is Required for Silencing Mouse Embryonic β-like Hemoglobin and Human Fetal Hemoglobin Expression.
Gudmundsdottir B; Gudmundsson KO; Klarmann KD; Singh SK; Sun L; Singh S; Du Y; Coppola V; Stockwin L; Nguyen N; Tessarollo L; Thorsteinsson L; Sigurjonsson OE; Gudmundsson S; Rafnar T; Tisdale JF; Keller JR
Cell Rep; 2018 Jun; 23(11):3236-3248. PubMed ID: 29898395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]